Startups and Medical Experts Drive Perimenopause Market Growth
AI-generated context summary requested by a Free News Reader user. Sourced via Gemini from publicly available information — no paywalled content was accessed.
You hit a paywall. Here’s the context on this topic based on publicly available information. We did not access any paywalled content. View original article.
Startups and Medical Experts Drive Perimenopause Market Growth
- The global perimenopause market was valued at approximately $4.54 billion in 2025 and is projected to reach about $7.24 billion by 2034.
- North America held the largest share of the perimenopause market in 2025, accounting for 38.73%.
Full Summary — powered by AI
The perimenopause market is experiencing significant growth, driven by an alliance of tech startups, medical experts, and a rising focus on women’s hormonal health, particularly among millennial women. This transitional phase before menopause, characterized by hormonal fluctuations and symptoms like hot flashes, mood changes, and sleep disturbances, has become a key area for new businesses and healthcare initiatives.
In 2025, the global perimenopause market was valued at around $4.54 billion and is expected to grow to approximately $7.24 billion by 2034, demonstrating a compound annual growth rate (CAGR) of 5.32% during this period. North America led this market in 2025 with a 38.73% share, with the US market alone estimated at $1.33 billion in the same year. This growth is partly attributed to increasing awareness and demand for symptom management therapies, as well as investments in “femtech” platforms focusing on women’s hormonal health.
Treatment options for perimenopause include hormone replacement therapy (HRT), which can alleviate hot flashes, night sweats, and vaginal dryness. Other approaches include vaginal estrogen for localized symptoms, antidepressants for hot flashes and mood stabilization, and non-hormonal medications like fezolinetant. Lifestyle adjustments such as a nutrient-dense diet, regular exercise, and adequate sleep are also recommended, often in combination with clinical treatments. The market for perimenopause women’s health and beauty supplements alone was valued at $9.013 billion in 2024 and is projected to reach $12.051 billion by 2030.
The increasing entry of millennial women into perimenopause is contributing to this market expansion, as this demographic is often more proactive in seeking and advocating for personalized care. This shift is also influenced by a growing recognition among employers and healthcare stakeholders of menopause as a significant health and workforce issue, leading to increased investment and innovation in solutions across therapeutics, care delivery, and consumer platforms.